Abstract

Abstract RNA binding proteins (RBPs) play critical roles in RNA metabolism and underlie multiple cellular functions. However, how RBPs act in cancer remains obscure. Using an RBP-focused RNAi screen and a genome-wide CRISPR/Cas9 knockout screen, we identified HNRNPL as an RBP required for prostate cancer growth. To understand the HNRNPL function mechanistically, we profiled the HNRNPL-bound RNA landscape by RIP-seq and linked these RBP-RNA interactions to multiple RNA regulatory processes. HNRNPL directly regulates the alternative splicing of a set of associated RNAs, including those encoding the androgen receptor (AR), the key lineage-specific prostate cancer oncogene. Interestingly, HNRNPL also regulates circular RNA formation. Moreover, we identified LARP, a novel HNRNPL-associated long noncoding RNA (lncRNA), as a cofactor of HNRNPL's gene regulatory function. Collectively, our data reveal HNRNPL and its RNA partners as novel players in prostate cancer growth, suggesting the potential to target RBPs or RBP-RNA interactions therapeutically. Citation Format: Teng Fei, Yiwen Chen, Myles Brown, X. Shirley Liu. Dependency of prostate cancer on HNRNPL and its associated RNAs. [abstract]. In: Proceedings of the AACR Special Conference on Noncoding RNAs and Cancer: Mechanisms to Medicines ; 2015 Dec 4-7; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2016;76(6 Suppl):Abstract nr IA11.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.